Kane Biotech Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 17 Apr 24 | SellCA$259,999 | Philip Renaud | Individual | 2,000,000 | CA$0.13 | |
| 11 Sep 23 | BuyCA$10,000 | Ray Dupuis | Individual | 125,000 | CA$0.08 | |
| 11 Sep 23 | BuyCA$10,000 | Marc Edwards | Individual | 125,000 | CA$0.08 | |
| 11 Sep 23 | BuyCA$250,001 | Richard Renaud | Individual | 3,125,000 | CA$0.08 |
Insider Trading Volume
Insider Buying: KNE insiders have only sold shares in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 49,043,590 | 37.2% |
| General Public | 82,800,977 | 62.8% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.6%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 27,389,711 | CA$3.6m | 0% | no data | |||
| 14,630,333 | CA$1.9m | 0% | no data | |||
| 5,888,142 | CA$765.5k | 0% | no data | |||
| 985,404 | CA$128.1k | 0% | no data | |||
| 150,000 | CA$19.5k | 0% | no data |